New and Innovative Treatments

Concurrent Session 8

Date: Saturday, April 26, 2025
Time: 8:45 AM to 10:15 AM

Description

Moderators

Ji Hyeon Ju 

Magali Cucchiarini 

8:45 AM - 9:25 AM

Role of Neural Crest Derived Cells (NCC) in Limb Regeneration of Regenerative Model Species 

Farida Djouad

9:25 AM - 9:35 AM

077: APOPTOTIC BODY-INSPIRED NANOTHERAPEUTICS TARGET BRD4-REGULATED SYNOVIAL MACROPHAGE TO ATTENUATE OSTEOARTHRITIS

Huan-Tian Zhang

9:35 AM - 9:45 AM

078: SELECTION OF AN APTAMER EXHIBITING HIGH AFFINITY FOR HEALTHY VERSUS OSTEOARTHRITIC HUMAN CHONDROCYTES

Huaizhi Chen

9:45 AM - 9:55 AM

079: DECELLULARIZED CARTILAGE EXTRACELLULAR MATRIX AS MULTIFACETED VISCOSUPPLEMENT FOR OSTEOARTHRITIS.

Eun Je Jeon

9:55 AM - 10:05 AM

080: COLLAGEN TARGETING NANOMICELLE WITH HIGH PENETRATION AND RETENTION IN CARTILAGE FOR IMPROVED TREATMENT OF OSTEOARTHRITIS

Saptomee Chakraborty

10:05 AM - 10:07 AM

081: MAGNETIC NANOEMULSIONS AS INTRAARTICULAR THERAPEUTIC STRATEGY FOR OSTEOARTHRITIS: IN VITRO AND IN VIVO FINDINGS

Luminita Labusca

10:07 AM - 10:09 AM

082: TARGETING NLRP3/NLRP1 INFLAMMASOMES: PRECLINICAL EFFICACY AND SAFETY OF INV-1498 FOR OSTEOARTHRITIS

Yurim Lee

10:09 AM - 10:11 AM

083: INTERLEUKIN 11 AS A NOVEL TARGET FOR ARTHROFIBROSIS THERAPY

Miguel Angel De Jesus

10:11 AM - 10:13 AM

084: ADENOSINE AND GUANOSINE-BASED OLIGONUCLEOTIDE ATTENUATES CATABOLIC PHENOTYPES IN CHONDROCYTES AND SLOWS PROGRESSION OF SURGICALLY INDUCED OSTEOARTHRITIS

Yoonhee Kim

10:13 AM - 10:15 AM Q & A